We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unveiling International Flavors (IFF) Q3 Outlook: Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Wall Street analysts expect International Flavors (IFF - Free Report) to post quarterly earnings of $1.06 per share in its upcoming report, which indicates a year-over-year increase of 19.1%. Revenues are expected to be $2.83 billion, up 0.5% from the year-ago quarter.
Over the last 30 days, there has been an upward revision of 0.6% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
With that in mind, let's delve into the average projections of some International Flavors metrics that are commonly tracked and projected by analysts on Wall Street.
According to the collective judgment of analysts, 'Net Sales- Nourish' should come in at $1.44 billion. The estimate suggests a change of -0.8% year over year.
Analysts forecast 'Net sales- Scent' to reach $629.75 million. The estimate indicates a change of +2.4% from the prior-year quarter.
Analysts expect 'Net Sales- Pharma Solutions' to come in at $240.35 million. The estimate points to a change of +1% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Net Sales- Health & Biosciences' of $531.83 million. The estimate points to a change of +2.7% from the year-ago quarter.
Analysts predict that the 'Adjusted Operating EBITDA- Nourish' will reach $207.69 million. The estimate compares to the year-ago value of $178 million.
The average prediction of analysts places 'Adjusted Operating EBITDA- Pharma Solutions' at $47.74 million. The estimate compares to the year-ago value of $47 million.
Based on the collective assessment of analysts, 'Adjusted Operating EBITDA- Scent' should arrive at $137.51 million. The estimate compares to the year-ago value of $131 million.
The consensus among analysts is that 'Adjusted Operating EBITDA- Health & Biosciences' will reach $155.24 million. Compared to the current estimate, the company reported $150 million in the same quarter of the previous year.
Over the past month, International Flavors shares have recorded returns of -1.8% versus the Zacks S&P 500 composite's +1% change. Based on its Zacks Rank #1 (Strong Buy), IFF will likely outperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Unveiling International Flavors (IFF) Q3 Outlook: Wall Street Estimates for Key Metrics
Wall Street analysts expect International Flavors (IFF - Free Report) to post quarterly earnings of $1.06 per share in its upcoming report, which indicates a year-over-year increase of 19.1%. Revenues are expected to be $2.83 billion, up 0.5% from the year-ago quarter.
Over the last 30 days, there has been an upward revision of 0.6% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
With that in mind, let's delve into the average projections of some International Flavors metrics that are commonly tracked and projected by analysts on Wall Street.
According to the collective judgment of analysts, 'Net Sales- Nourish' should come in at $1.44 billion. The estimate suggests a change of -0.8% year over year.
Analysts forecast 'Net sales- Scent' to reach $629.75 million. The estimate indicates a change of +2.4% from the prior-year quarter.
Analysts expect 'Net Sales- Pharma Solutions' to come in at $240.35 million. The estimate points to a change of +1% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Net Sales- Health & Biosciences' of $531.83 million. The estimate points to a change of +2.7% from the year-ago quarter.
Analysts predict that the 'Adjusted Operating EBITDA- Nourish' will reach $207.69 million. The estimate compares to the year-ago value of $178 million.
The average prediction of analysts places 'Adjusted Operating EBITDA- Pharma Solutions' at $47.74 million. The estimate compares to the year-ago value of $47 million.
Based on the collective assessment of analysts, 'Adjusted Operating EBITDA- Scent' should arrive at $137.51 million. The estimate compares to the year-ago value of $131 million.
The consensus among analysts is that 'Adjusted Operating EBITDA- Health & Biosciences' will reach $155.24 million. Compared to the current estimate, the company reported $150 million in the same quarter of the previous year.
View all Key Company Metrics for International Flavors here>>>
Over the past month, International Flavors shares have recorded returns of -1.8% versus the Zacks S&P 500 composite's +1% change. Based on its Zacks Rank #1 (Strong Buy), IFF will likely outperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>